BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, announced today an oversubscribed $130 million Series C funding round led by Kinnevik ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback